Health Conditions A-Z Infectious Diseases COVID-19 What Is Ground Glass Opacity (GGO)? By Leah Groth Leah Groth With decades of experience as a health, wellness, and fitness journalist, Leah Groth has one mission: To help you become the healthiest version of yourself. health's editorial guidelines Updated on October 23, 2024 Medically reviewed by Sanja Jelic, MD Medically reviewed by Sanja Jelic, MD Sanja Jelic, MD, is a board-certified pulmonologist and sleep specialist who teaches in the Division of Pulmonary, Allergy, and Critical Care Medicine at the Columbia University College of Physicians and Surgeons. learn more Close MTStock Studio / Getty Images Ground glass opacity (GGO) is an abnormal finding that shows up on computed tomography (CT) scans in people's lungs as a result of several possible diseases. These changes are described as an "opacity," meaning they darken the CT, showing areas where the lung structure is denser than the tissue around it. Some people can develop these lung changes after COVID-19. GGOs can help diagnose and monitor complications from COVID, such as pneumonia (inflammation of the lungs). GGOs are not specific to COVID. They can be caused by other health conditions and infections that affect the lungs. Read on to learn about GGO and what it means to have it. What Does Ground Glass Opacity (GGO) Mean? GGOs indicate abnormalities in the lungs. A healthcare provider can detect GGOs on a chest CT scan as the result of a range of lung diseases. GGOs point to increased density in the lungs, which might mean that fluid or other substances have filled air spaces. Research has shown that GGOs might also indicate the walls of alveoli (air sacs in the lungs) or spaces between the lungs have thickened. What Do Ground-Glass Opacities Look Like? Normal lung tissue appears black on a CT scan, but GGOs are lightly colored or gray patches. They resemble ground glass, which is still transparent but has a matte finish. These lighter patches do not completely obscure the other structures in the lungs. This makes them different from cancerous lesions, which often appear solid. GGOs, in contrast, cause a haziness that overlays an area of the lung. A healthcare provider will still be able to identify underlying structures of the lung (e.g., airways, blood vessels, and lung tissue). Types of GGO The shape, size, and number of GGOs may indicate the cause. Types of GGOs include: Centrilobular: Forms in one or multiple lobules, or small subdivisions within each lobe of the lungsCrazy paving: Appears in a linear pattern within enlarged lobulesHalo sign: Permeates the space around the nodules, or a dense spot in the lung (which might also appear reversed)Diffuse: Forms in several lobes within one or both lungs if fluid fills air spacesMosaic: Shows up if something blocks the bronchioles (small airways in the lungs) or pulmonary arteries COVID-19 and Ground-Glass Opacities A study published in 2021 looked at people hospitalized with COVID symptoms and who had GGOs on initial lung scans. The researchers rescanned their lungs at three and nine months after hospital discharge. They found that 78% of people had residual GGOs three months post-discharge, and 24% had GGOs nine months post-discharge. Another study published in 2021 looked at one-year outcomes in people who were hospitalized with COVID. The study authors found a decrease in GGOs by 12 months and that 78% of people still had GGOs showing up on lung scans. Both studies showed that people had other respiratory issues in addition to GGOs. The study authors urged long-term follow-up for anyone who had COVID, especially those who had severe illness. Other COVID-19-Associated Changes on Chest CT Scans GGOs are some of the most common findings seen in people with COVID-related pneumonia. Other imaging appearances also can signal COVID, such as consolidation and septal thickening. Consolidation is a white portion on a CT scan that signifies fluid is present. Septal thickening is a thickening of the connective tissue in the lung. This finding may also indicate fluid, fibrous tissue, or cell infiltration. These terms are essential to know, especially if a healthcare provider mentions GGOs when treating you for COVID or another illness. Remember that a COVID diagnosis does not automatically lead to a worsened condition in which these GGOs show up in a CT scan. An abnormal scan likewise does not always signal COVID. Some people will have completely different radiologic findings, while others will have no abnormalities. Other Causes It's important to remember that GGOs are not specific to COVID. A healthcare provider might detect GGOs in many different settings. Some of the most common causes include lung damage from congestive heart failure, diffuse alveolar hemorrhage, interstitial lung diseases, lung cancer, and viral pneumonia. Congestive Heart Failure Heart failure occurs if your heart is unable to pump blood throughout your body efficiently. As a result, your other organs may not work as they typically do. Heart failure may also cause fluid to gather in the air spaces in your lungs, known as pulmonary edema. This complication may show up as GGOs on a CT scan. Diffuse Alveolar Hemorrhage Alveolar hemorrhage is a life-threatening complication that causes bleeding into the alveoli. A study published in 2019 found that this complication appeared as diffuse GGOs on a CT scan. Interstitial Lung Diseases Interstitial lung diseases cause inflammation or scarring of the lungs, which makes it hard to breathe. These complications cause the air spaces in the lungs to become thickened. Research has shown that GGOs may indicate interstitial thickening in the lungs. Lung Cancer Research has found that GGOs may be present in some patients with lung cancer. Viral Pneumonia One of the most common diagnoses for GGOs is viral pneumonia, or inflammation of the lungs. Viruses that may cause pneumonia include coronavirus, cytomegalovirus, herpes simplex virus (HSV), influenza (flu) virus, and respiratory syncytial virus (RSV). Diagnosis A healthcare provider can detect GGOs and their type using a chest CT scan. This diagnostic test uses X-rays to take detailed pictures of the inside of your chest, including the lungs. You may require further tests if abnormalities like GGOs show up on a chest CT scan. Other diagnostic tests include: Bronchoscopy: A healthcare provider will insert a tube with a small camera and light (bronchoscope) through your nose or mouth to look down your throat and into your lungs. Lung function tests: These include pulse oximetry and spirometry, which measure how well your lungs work. Treatment Treatment depends on the cause of GGOs. For example, a healthcare provider may prescribe antiviral drugs if you have COVID-related pneumonia. Some people with severe viral pneumonia require treatment at the hospital. Other treatments may include: MedicinesOxygen therapy for low blood oxygen levels Lung cancer treatment will depend on the type and severity of the cancer. You may require chemotherapy, radiation therapy, or surgery to remove cancer cells. A Quick Review GGOs show up as lighter-colored or gray patches on chest CT scans of the lungs. This finding can indicate COVID-related lung conditions, such as pneumonia. Other causes of GGOs include congestive heart failure, diffuse alveolar hemorrhage, interstitial lung diseases, and lung cancer. Treatment depends on what's causing GGOs but may include medicines, lung transplants, and oxygen therapy. The information in this story is accurate as of publication. However, as the situation surrounding COVID-19 continues to evolve, it's possible that some data have changed since publication. While Health is trying to keep our stories as up-to-date as possible, we also encourage readers to stay informed on news and recommendations for their own communities by using the CDC, WHO, and their local public health department as resources. Was this page helpful? Thanks for your feedback! Tell us why! Other Submit 18 Sources Health.com uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Sharma S. Drawing insights from COVID-19-infected patients using CT scan images and machine learning techniques: A study on 200 patients. Environ Sci Pollut Res Int. 2020;27(29):37155-37163. doi:10.1007/s11356-020-10133-3 Kong W, Agarwal PP. Chest imaging appearance of COVID-19 infection. Radiol Cardiothorac Imaging. 2020;2(1):e200028. doi:10.1148/ryct.2020200028 Zhuo Y, Shan F, Yang S, et al. Advances in differential diagnosis of pulmonary ground glass opacity on high resolution computed tomography and histopathology. Radiol. Infect. Dis. 2020;7(1):7-11. doi:10.1016/j.jrid.2020.03.003 Cozzi D, Cavigli E, Moroni C, et al. Ground-glass opacity (GGO): A review of the differential diagnosis in the era of COVID-19. Jpn J Radiol. 2021;39(8):721-732. doi:10.1007/s11604-021-01120-w Wu X, Liu X, Zhou Y, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study. Lancet Respir Med. 2021;9(7):747-754. doi:10.1016/S2213-2600(21)00174-0 Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 2021;398(10302):747-758. doi:10.1016/S0140-6736(21)01755-4 Ye Z, Zhang Y, Wang Y, et al. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): A pictorial review. Eur Radiol. 2020;30(8):4381-4389. doi:10.1007/s00330-020-06801-0 Walker CM, Abbott GF, Greene RE, et al. Imaging pulmonary infection: Classic signs and patterns. AJR Am J Roentgenol. 2014;202(3):479-492. doi:10.2214/AJR.13.11463 M C, R D, S W. Diagnosis and treatment of high-risk bilateral lung ground-glass opacity nodules. Asian journal of surgery. 2024;47(7). doi:10.1016/j.asjsur.2024.01.072 MedlinePlus. Heart failure. Malone A, Gariwala V, O'Neill C. Congestive heart failure presenting as diffuse pulmonary nodules on CT. Radiol Case Rep. 2021;17(2):364-367. doi:10.1016/j.radcr.2021.11.006 Stainer A, Rice A, Devaraj A, et al. Diffuse alveolar haemorrhage associated with subsequent development of ANCA positivity and emphysema in three young adults. BMC Pulm Med. 2019;19(1):185. doi:10.1186/s12890-019-0947-y MedlinePlus. Interstitial lung disease. Huang C, Wang C, Wang Y, et al. The prognostic significance of pure ground glass opacities in lung cancer computed tomographic images. J Cancer. 2019;10(27):6888-6895. doi:10.7150/jca.33132 Freeman AM, Leigh J. Viral pneumonia. In: StatPearls. StatPearls Publishing; 2024. MedlinePlus. CT scan. MedlinePlus. Pneumonia. MedlinePlus. Lung cancer.